Lindbrook Capital’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $33.3K | Buy |
1,174
+1
| +0.1% | +$28 | ﹤0.01% | 1146 |
|
|
2024
Q4 | $48.8K | Sell |
1,173
-99
| -8% | -$4.12K | ﹤0.01% | 820 |
|
|
2024
Q3 | $85K | Sell |
1,272
-651
| -34% | -$43.5K | 0.01% | 609 |
|
|
2024
Q2 | $228K | Buy |
1,923
+448
| +30% | +$53.2K | 0.02% | 336 |
|
|
2024
Q1 | $157K | Buy |
1,475
+84
| +6% | +$8.95K | 0.01% | 415 |
|
|
2023
Q4 | $138K | Buy |
1,391
+411
| +42% | +$40.9K | 0.01% | 432 |
|
|
2023
Q3 | $101K | Sell |
980
-44
| -4% | -$4.55K | 0.01% | 468 |
|
|
2023
Q2 | $124K | Buy |
1,024
+130
| +15% | +$15.8K | 0.01% | 431 |
|
|
2023
Q1 | $137K | Sell |
894
-134
| -13% | -$20.6K | 0.02% | 397 |
|
|
2022
Q4 | $185K | Buy |
1,028
+183
| +22% | +$32.9K | 0.02% | 345 |
|
|
2022
Q3 | $100K | Sell |
845
-36
| -4% | -$4.26K | 0.02% | 428 |
|
|
2022
Q2 | $126K | Sell |
881
-1,381
| -61% | -$198K | 0.02% | 397 |
|
|
2022
Q1 | $390K | Buy |
2,262
+148
| +7% | +$25.5K | 0.06% | 189 |
|
|
2021
Q4 | $537K | Buy |
2,114
+1,698
| +408% | +$431K | 0.08% | 154 |
|
|
2021
Q3 | $160K | Buy |
416
+33
| +9% | +$12.7K | 0.04% | 186 |
|
|
2021
Q2 | $90K | Buy |
383
+24
| +7% | +$5.64K | 0.02% | 310 |
|
|
2021
Q1 | $47K | Buy |
359
+24
| +7% | +$3.14K | 0.01% | 463 |
|
|
2020
Q4 | $35K | Buy |
335
+150
| +81% | +$15.7K | 0.01% | 509 |
|
|
2020
Q3 | $13K | Buy |
185
+129
| +230% | +$9.07K | ﹤0.01% | 758 |
|
|
2020
Q2 | $4K | Buy |
56
+20
| +56% | +$1.43K | ﹤0.01% | 1182 |
|
|
2020
Q1 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 1506 |
|